Phathom Pharmaceuticals Inc (PHAT) USD0.0001
1.03%- This stock can be held in a
Stocks and Shares ISASell:$11.74
Buy:$11.77
Change:
$0.30
(2.62%)
$0.30
(2.62%)Market closed | Prices delayed by at least 15 minutes
Sell:$11.74
Buy:$11.77
Change:$0.30
(2.62%)
$0.30
(2.62%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 July 2024 | Terrie CurranPresident/CEO | Sell Tax related | 33,848 | $11.72 | $396,698.56 | 377,734 |
| 15 July 2024 | Azmi NabulsiCOO | Sell Tax related | 10,901 | $11.72 | $127,759.72 | 240,421 |
| 15 July 2024 | Molly HendersonCFO | Sell Tax related | 4,325 | $11.72 | $50,689.00 | 99,447 |
| 29 May 2024 | Frank Lutz KarbeIndependent Director | Buy Regular purchase transaction | 25,000 | $10.16 | $254,112.50 | 44,500 |
| 8 April 2024 | Molly HendersonCFO | Sell Tax related | 3,435 | $11.10 | $38,128.50 | 95,263 |
| 22 March 2024 | Terrie CurranPresident/CEO | Sell Regular sell transaction (market) | 16,851 | $9.11 | $153,512.61 | 410,784 |
| 24 January 2024 | TAKEDA PHARMACEUTICAL COMPANY LIMITEDPublic Company | Sell Regular sell transaction (market) | 3,703,703 | $8.10 | $29,999,994.30 | 3,755,583 |
| 19 January 2024 | Molly HendersonCFO | Sell Tax related | 6,307 | $7.75 | $48,900.06 | 98,698 |
| 20 November 2023 | Molly HendersonCFO | Sell Tax related | 2,127 | $7.24 | $15,402.67 | 103,061 |
| 8 November 2023 | Asit ParikhIndependent Director | Buy Regular purchase transaction | 2,500 | $7.80 | $19,500.00 | 55,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 24 January 2024 | TAKEDA PHARMACEUTICAL COMPANY LIMITEDPublic Company | Sell Regular sell transaction (market) | 3,703,703 | $8.10 | $29,999,994.30 | 3,755,583 |
| 15 July 2024 | Terrie CurranPresident/CEO | Sell Tax related | 33,848 | $11.72 | $396,698.56 | 377,734 |
| 29 May 2024 | Frank Lutz KarbeIndependent Director | Buy Regular purchase transaction | 25,000 | $10.16 | $254,112.50 | 44,500 |
| 22 March 2024 | Terrie CurranPresident/CEO | Sell Regular sell transaction (market) | 16,851 | $9.11 | $153,512.61 | 410,784 |
| 15 July 2024 | Azmi NabulsiCOO | Sell Tax related | 10,901 | $11.72 | $127,759.72 | 240,421 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.